Phillip G. Febbo
Phillip G. Febbo is Chief Medical Officer of Illumina, Inc. He is also on the board of Varian Medical Systems, Inc., American College of Medical Genetics & Genomics and Acmg Foundation For Genetic & Genomic Medicine and Member of American Society for Clinical Investigation.
In his past career Dr. Febbo held the position of Chief Medical Officer for Genomic Health, Inc., Associate Professor at Duke University and Professor at The University of California, San Francisco.
Phillip G. Febbo received an undergraduate degree from Dartmouth College and a doctorate from The University of California, San Francisco.
Transactions
Date
Transaction
Value
| 11/08/2021 | 1,000 | Disposition at $406.83 per share. | 406,830 |
| 11/05/2021 | 446 | Derivative/Non-derivative trans. at $408.14 per share. | 182,031 |
| 06/11/2021 | 290 | Disposition at $449.02 per share. | 130,216 |
| 06/11/2021 | 400 | Disposition at $447.65 per share. | 179,060 |
| 06/11/2021 | 310 | Disposition at $446.17 per share. | 138,313 |
| 04/05/2021 | 131 | Derivative/Non-derivative trans. at $384.54 per share. | 50,375 |
| 02/17/2021 | 1,454 | Derivative/Non-derivative trans. at $494.24 per share. | 718,625 |
| 02/17/2021 | 3,173 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 02/17/2021 | 350 | Award at $0 per share. | 0 |
| 02/09/2021 | 1,380 | Award at $0 per share. | 0 |
| 11/06/2020 | 155 | Disposition at $310.1 per share. | 48,066 |
| 11/05/2020 | 192 | Derivative/Non-derivative trans. at $311.72 per share. | 59,851 |
| 04/16/2020 | 173 | Disposition at $300 per share. | 51,900 |
| 04/05/2020 | 92 | Derivative/Non-derivative trans. at $278.01 per share. | 25,577 |
| 02/05/2020 | 1,249 | Award at $0 per share. | 0 |
| 11/14/2019 | 155 | Disposition at $300 per share. | 46,500 |
| 11/05/2019 | 83 | Derivative/Non-derivative trans. at $300.87 per share. | 24,973 |
